Sleep Dysfunction in COVID-19 Patients: Prevalence, Risk Factors, Mechanisms, and Management
Abstract
:1. Introduction
2. Sleep Dysfunction in COVID-19 Patients
2.1. Prevalence of Sleep Problems in COVID-19 Sufferers
2.2. Sleep Impairment as a Neurological Symptom of SARS-CoV2
2.3. Role of Sleep in the Immune Response to COVID-19
3. Sleep Impairment and Psychological Distress in COVID-19 Patients
4. Obstructive Sleep Apnea (OSA) during COVID-19 Pandemic
4.1. Association between OSA and COVID-19
4.2. Management of OSA during COVID-19
5. Management of Sleep-Related Disorders in COVID-19 Patients
6. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Borges do Nascimento, I.J.; Cacic, N.; Abdulazeem, H.M.; von Groote, T.C.; Jayarajah, U.; Weerasekara, I.; Esfahani, M.A.; Civile, V.T.; Marusic, A.; Jeroncic, A.; et al. Novel coronavirus infection (COVID-19) in humans: A scoping review and meta-analysis. J. Clin. Med. 2020, 9, 941. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- World Health Organization. Coronavirus Disease (COVID-19) Pandemic. Available online: https://www.who.int/emergencies/diseases/novel-coronavirus-2019 (accessed on 2 May 2020).
- Triggle, C.R.; Bansal, D.; Farag, E.A.; Ding, H.; Sultan, A.A. COVID-19: Learning from lessons to guide treatment and prevention interventions. MSphere 2020, 5, e00317–e00320. [Google Scholar] [CrossRef]
- Ji, D.; Ji, Y.J.; Duan, X.Z.; Li, W.G.; Sun, Z.Q.; Song, X.A.; Meng, Y.H.; Tang, H.M.; Chu, F.; Niu, X.X.; et al. Prevalence of psychological symptoms among Ebola survivors and healthcare workers during the 2014–2015 Ebola outbreak in Sierra Leone: A cross-sectional study. Oncotarget 2017, 8, 12784–12791. [Google Scholar] [CrossRef] [Green Version]
- Lin, C.-Y.; Peng, Y.-C.; Wu, Y.-H.; Chang, J.; Chan, C.-H.; Yang, D.-Y. The psychological effect of severe acute respiratory syndrome on emergency department staff. Emerg. Med. J. 2007, 24, 12–17. [Google Scholar] [CrossRef]
- Mohammed, A.; Sheikh, T.L.; Gidado, S.; Poggensee, G.; Nguku, P.; Olayinka, A.; Ohuabunwo, C.; Waziri, N.; Shuaib, F.; Adeyemi, J.; et al. An evaluation of psychological distress andsocial support of survivors and contacts of Ebola virus disease infection and theirrelatives in Lagos, Nigeria: A cross sectional study—2014. BMC Public Health 2015, 15, 824. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Krishnamoorthy, Y.; Nagarajan, R.; Saya, G.K.; Menon, V. Prevalence of psychological morbidities among general population, healthcare workers and COVID-19 patients amidst the COVID-19 pandemic: A systematic review and meta-analysis. Psychiatry Res. 2020, 293, 113382. [Google Scholar] [CrossRef]
- Bo, H.X.; Li, W.; Yang, Y.; Wang, Y.; Zhang, Q.; Cheung, T.; Wu, X.; Xiang, Y.T. Posttraumatic stress symptoms and attitude toward crisis mental health services among clinically stable patients with COVID-19 in China. Psychol. Med. 2021, 51, 1052–1053. [Google Scholar] [CrossRef] [Green Version]
- Zhang, J.; Lu, H.; Zeng, H.; Zhang, S.; Du, Q.; Jiang, T.; Du, B. The differential psychological distress of populations affected by the COVID-19 pandemic. Brain Behav. Immun. 2020, 87, 49–50. [Google Scholar] [CrossRef] [PubMed]
- WHO Summary of ICD Coding for COVID-19. Available online: http://www.whofic.org.za/SummaryICDcoding.pdf (accessed on 15 April 2021).
- Lopez-Leon, S.; Wegman-Ostrosky, T.; Perelman, C.; Sepulveda, R.; Rebolledo, P.A.; Cuapio, A.; Villapol, S. More than 50 long-term effects of COVID-19: A systematic review and meta-analysis. Sci. Rep. 2021, 11, 16144. [Google Scholar] [CrossRef] [PubMed]
- Pakpour, A.H.; Griffiths, M.D.; Ohayon, M.M.; Brostreom, A.; Lin, C.-Y. A good sleep: The role of factors in psychosocial health. Front. Neurosci. 2020, 14, 520. [Google Scholar] [CrossRef]
- Medic, G.; Wille, M.; Hemels, M.E. Short- and long-term health consequences of sleep disruption. Nat. Sci. Sleep 2017, 9, 151–161. [Google Scholar] [CrossRef] [Green Version]
- Alimoradi, Z.; Broström, A.; Tsang, H.W.H.; Griffiths, M.D.; Haghayegh, S.; Ohayon, M.M.; Lin, C.Y.; Pakpour, A.H. Sleep problems during COVID-19 pandemic and its’ association to psychological distress: A systematic review and meta-analysis. EClinicalMedicine 2021, 36, 100916. [Google Scholar] [CrossRef]
- Jahrami, H.; BaHamma, A.S.; Bragazzi, N.L.; Saif, Z.; Faris, M.; Vitiello, M.V. Sleep problems during the COVID-19 pandemic by population: A systematic review and meta-analysis. J. Clin. Sleep Med. 2021, 17, 299–313. [Google Scholar] [CrossRef] [PubMed]
- Wu, K.; Wei, X. Analysis of psychological and sleep status and exercise rehabilitation of front-line clinical staff in the fight against COVID-19 in China. Med. Sci. Monit. Basic Res. 2020, 26, 924085. [Google Scholar] [CrossRef] [PubMed]
- Jahrami, H.; BaHammam, A.S.; AlGahtani, H.; Ebrahim, A.; Faris, M.; AlEid, K.; Saif, Z.; Haji, E.; Dhahi, A.; Marzooq, H.; et al. The examination of sleep quality for frontline healthcare workers during the outbreak of COVID-19. Sleep Breath. 2021, 25, 503–511. [Google Scholar] [CrossRef] [PubMed]
- Kumar, A.; Bhat, P.S.; Ryali, S. Study of quality of life among health workers and psychosocial factors influencing it. Ind. Psychiatry J. 2018, 27, 96. [Google Scholar]
- Mohanty, A.; Kabi, A.; Mohanty, A.P. Health problems in healthcare workers: A review. J. Fam. Med. Prim. Care 2019, 8, 2568. [Google Scholar]
- Pappa, S.; Sakkas, N.; Sakka, E. A year in review: Sleep dysfunction and psychological distress in healthcare workers during the COVID-19 pandemic. Sleep Med. 2021. [Google Scholar] [CrossRef]
- Zeng, L.-N.; Yang, Y.; Wang, C.; Li, X.H.; Xiang, Y.F.; Hall, B.J.; Ungvari, G.S.; Li, C.Y.; Chen, C.; Chen, L.G.; et al. Prevalence of poor sleep quality in nursing staff: A meta-analysis of observational studies. Behav. Sleep Med. 2020, 18, 746–759. [Google Scholar] [CrossRef]
- Wang, W.; Song, W.; Xia, Z.; He, Y.; Tang, L.; Hou, J.; Lei, S. Sleep disturbance and psychological profiles of medical staff and non-medical staff during the early outbreak of COVID-19 in Hubei Province, China. Front. Psychiatry 2020, 11, 733. [Google Scholar] [CrossRef]
- Ornell, F.; Schuch, J.B.; Sordi, A.O.; Kessler, F.H.P. “Pandemic fear” and COVID-19: Mental health burden and strategies. Braz. J. Psychiatry 2020, 42, 232–235. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Jiang, Z.; Zhu, P.; Wang, L.; Pang, M.; Ma, S.; Tang, X. Psychological distress and sleep quality of COVID-19 patients in Wuhan, a lockdown city as the epicenter of COVID-19. J. Psychiatr Res. 2021, 136, 595–602. [Google Scholar] [CrossRef]
- Edinger, J.D.; Arnedt, J.T.; Bertisch, S.M.; Carney, C.E.; Harrington, J.J.; Lichstein, K.L.; Sateia, M.J.; Troxel, W.M.; Zhou, E.S.; Kazmi, U.; et al. Behavioral and psychological treatments for chronic insomnia disorder in adults: An American Academy of Sleep Medicine clinical practice guideline. J. Clin. Sleep Med. 2021, 17, 255–262. [Google Scholar] [CrossRef]
- Zhang, W.R.; Wang, K.; Yin, L.; Zhao, W.F.; Xue, Q.; Peng, M.; Min, B.Q.; Tian, Q.; Leng, H.X.; Du, J.L.; et al. Mental health and psychosocial problems of medical health workers during the COVID-19 epidemic in China. Psychother. Psychosomat. 2020, 89, 242–250. [Google Scholar] [CrossRef] [PubMed]
- Liu, H.Q.; Yuan, B.; An, Y.W.; Chen, K.J.; Hu, Q.; Hu, X.P.; Zhao, J.; Dong, Y.; Chen, Y.X.; Li, W.X.; et al. Clinical characteristics and follow-up analysis of 324 discharged COVID-19 patients in Shenzhen during the recovery period. Int. J. Med. Sci. 2021, 18, 347–355. [Google Scholar] [CrossRef]
- Xu, F.; Wang, X.; Yang, Y.; Zhang, K.; Shi, Y.; Xia, L.; Hu, X.; Liu, H. Depression and insomnia in COVID-19 survivors: A cross-sectional survey from Chinese rehabilitation centers in Anhui province. Sleep Med. 2021. [Google Scholar] [CrossRef]
- Sher, L. The impact of the COVID-19 pandemic on suicide rates. QJM 2020, 113, 707–712. [Google Scholar] [CrossRef]
- Becker, P.M. Overview of sleep management during COVID-19. Sleep Med. 2021. [Google Scholar] [CrossRef]
- Buysse, D.J.; Reynolds, C.F.; Monk, T.H.; Berman, S.R.; Kupfer, D.J. The Pittsburgh Sleep Quality Index: A new instrument for psychiatric practice and research. Psychiatry Res. 1989, 28, 193–213. [Google Scholar] [CrossRef]
- Bastien, C.H.; Vallières, A.; Morin, C.M. Validation of the Insomnia Severity Index as an outcome measure for insomnia research. Sleep Med. 2001, 2, 297–307. [Google Scholar] [CrossRef]
- Soldatos, C.R.; Dikeos, D.G.; Paparrigopoulos, T.J. Athens Insomnia Scale: Validation of an instrument based on ICD-10 criteria. J. Psychosomat. Res. 2000, 48, 555–560. [Google Scholar] [CrossRef]
- Jackson, C.L.; Johnson, D.A. Sleep disparities in the era of the COVID-19 pandemic highlight the urgent need to address social determinants of health like the virus of racism. J. Clin. Sleep Med. 2020, 16, 1401–1402. [Google Scholar] [CrossRef] [PubMed]
- Troyer, E.A.; Kohn, J.N.; Hong, S. Are we facing a crashing wave of neuropsychiatric sequelae of COVID-19? Neuropsychiatric symptoms and potential immunologic mechanisms. Brain Behav. Immun. 2020, 87, 34–39. [Google Scholar] [CrossRef] [PubMed]
- Liguori, C.; Pierantozzi, M.; Spanetta, M.; Sarmati, L.; Cesta, N.; Iannetta, M.; Ora, J.; Mina, G.G.; Puxeddu, E.; Balbi, O.; et al. Subjective neurological symptoms frequently occur in patients with SARS-CoV2 infection. Brain Behav. Immun. 2020, 88, 11–16. [Google Scholar] [CrossRef] [PubMed]
- Frontera, J.A.; Sabadia, S.; Lalchan, R.; Fang, T.; Flusty, B.; Millar-Vernetti, P.; Snyder, T.; Berger, S.; Yang, D.; Granger, A.; et al. A prospective study of neurologic disorders in hospitalized COVID-19 patients in New York City. Neurology 2021, 96, 575–586. [Google Scholar] [CrossRef]
- Rogers, J.P.; Chesney, E.; Oliver, D.; Pollak, T.A.; McGuire, P.; Fusar-Poli, P.; Zandi, M.S.; Lewis, G.; David, A.S. Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: A systematic review and meta-analysis with comparison to the COVID-19 pandemic. Lancet Psychiatry 2020, 7, 611–627. [Google Scholar] [CrossRef]
- Mônico-Neto, M.; Dos Santos, R.V.T.; Moreira Antunes, H.K.M. The world war against the COVID-19 outbreak: Don’t forget to sleep! J. Clin. Sleep Med. 2020, 16, 1215. [Google Scholar] [CrossRef]
- Silva, F.R.D.; Guerreiro, R.C.; Andrade, H.A.; Stieler, E.; Silva, A.; de Mello, M.T. Does the compromised sleep and circadian disruption of night and shiftworkers make them highly vulnerable to 2019 coronavirus disease (COVID-19)? Chronobiol. Int. 2020, 37, 607–617. [Google Scholar] [CrossRef]
- Irwin, M.R. Why sleep is important for health:a psychoneuroimmunology perspective. Annu. Rev. Psychol. 2015, 66, 143–172. [Google Scholar] [CrossRef] [Green Version]
- Mao, L.; Jin, H.; Wang, M.; Hu, Y.; Chen, S.; He, Q.; Chang, J.; Hong, C.; Zhou, Y.; Wang, D.; et al. Neurologic manifestations of hospitalized patients with Coronavirus Disease 2019 in Wuhan, China. JAMA Neurol. 2020, 77, 683–690. [Google Scholar] [CrossRef] [Green Version]
- Zambrelli, E.; Canevini, M.; Gambini, O.; D’Agostino, A. Delirium and sleep disturbances in COVID-19: A possible role for melatonin in hospitalized patients? Sleep Med. 2020, 70, 111. [Google Scholar] [CrossRef]
- Vitale, J.A.; Perazzo, P.; Silingardi, M.; Biffi, M.; Banfi, G.; Negrini, F. Is disruption of sleep quality a consequence of severe Covid-19 infection? A case-series examination. Chronobiol. Int. 2020, 37, 1110–1114. [Google Scholar] [CrossRef] [PubMed]
- Zhang, J.; Xu, D.; Xie, B.; Zhang, Y.; Huang, H.; Liu, H.; Chen, H.; Sun, Y.; Shang, Y.; Hashimoto, K.; et al. Poor-sleep is associated with slow recovery from lymphopenia and an increased need for ICU care in hospitalized patients with COVID-19: A retrospective cohort study. Brain Behav. Immun. 2020, 88, 50–58. [Google Scholar] [CrossRef]
- Krueger, J. The role of cytokines in sleep regulation. Curr. Pharm. Des. 2008, 14, 3408–3416. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Patel, S.R.; Malhotra, A.; Gao, X.; Hu, F.B.; Neuman, M.I.; Fawzi, W.W. A prospective study of sleep duration and pneumonia risk in women. Sleep 2012, 35, 97–101. [Google Scholar] [CrossRef] [Green Version]
- Prather, A.A.; Leung, C.W. Association of insufficient sleep with respiratory infection among adults in the United States. JAMA Intern. Med. 2016, 176, 850. [Google Scholar] [CrossRef] [PubMed]
- Huang, B.; Niu, Y.; Zhao, W.; Bao, P.; Li, D. Reduced sleep in the week prior to diagnosis of COVID-19 is associated with the severity of COVID-19. Nat. Sci. Sleep 2020, 12, 999–1007. [Google Scholar] [CrossRef]
- Wang, C.; Pan, R.; Wan, X.; Tan, Y.; Xu, L.; Ho, C.S.; Ho, R.C. Immediate psychological responses and associated factors during the initial stage of the 2019 coronavirus disease (COVID-19) epidemic among the general population in China. Int. J. Environ. Res. Public Health 2020, 17, 1729. [Google Scholar] [CrossRef] [Green Version]
- Vindegaard, N.; Benros, M.E. COVID-19 pandemic and mental health consequences: Systematic review of the current evidence. Brain Behav. Immun. 2020, 89, 531–542. [Google Scholar] [CrossRef]
- Salari, N.; Hosseinian-Far, A.; Jalali, R.; Vaisi-Raygani, A.; Rasoulpoor, S.; Mohammadi, M.; Rasoulpoor, S.; Khaledi-Paveh, B. Prevalence of stress, anxiety, depression among the general population during the COVID-19 pandemic: A systematic review and meta-analysis. Global Health 2020, 16, 57. [Google Scholar] [CrossRef]
- Lin, C.-Y.; Brostrom, A.; Griffiths, M.D.; Pakpour, A.H. Investigating mediated effects of fear of COVID-19 and COVID-19 misunderstanding in the association between problematic social media use, psychological distress, and insomnia. Internet Intervent. 2020, 21, 100345. [Google Scholar] [CrossRef] [PubMed]
- Dai, L.-L.; Wang, X.; Jiang, T.-C.; Li, P.-F.; Wang, Y.; Wu, S.-J.; Jia, L.Q.; Liu, M.; An, L.; Cheng, Z. Anxiety and depressive symptoms among COVID-19 patients in Jianghan Fangcang Shelter Hospital in Wuhan, China. PLoS ONE 2020, 15, e0238416. [Google Scholar] [CrossRef] [PubMed]
- Huang, C.; Huang, L.; Wang, Y.; Li, X.; Ren, L.; Gu, X.; Kang, L.; Guo, L.; Liu, M.; Zhou, X.; et al. 6-month consequences of COVID-19 in patients discharged from hospital: A cohort study. Lancet 2021, 397, 220–232. [Google Scholar] [CrossRef]
- Deng, J.; Zhou, F.; Hou, W.; Silver, Z.; Wong, C.Y.; Chang, O.; Huang, E.; Zuo, Q.K. The prevalence of depression, anxiety, and sleep disturbances in COVID-19 patients: A meta-analysis. Ann. N. Y. Acad. Sci. 2021, 1486, 90–111. [Google Scholar] [CrossRef]
- Liu, X.; Lin, H.; Jiang, H.; Li, R.; Zhong, N.; Su, H.; Li, Y.; Zhao, M. Clinical characteristics of hospitalized patients with schizophrenia who were suspected to have coronavirus disease (COVID-19) in Hubei Province, China. Gen. Psychiatry 2020, 33, 100222. [Google Scholar] [CrossRef] [Green Version]
- Lin, L.-y.; Wang, J.; Ou-yang, X.-y.; Miao, Q.; Chen, R.; Liang, F.X.; Zhang, Y.P.; Tang, Q.; Wang, T. The immediate impact of the 2019 novel coronavirus (COVID-19) outbreak on subjective sleep status. Sleep Med. 2021, 77, 348–354. [Google Scholar] [CrossRef]
- Yang, J.; Zheng, Y.; Gou, X.; Pu, K.; Chen, Z.; Guo, Q.; Ji, R.; Wang, H.; Wang, Y.; Zhou, Y. Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: A systematic review and meta-analysis. Int. J. Infect. Dis. 2020, 94, 91–95. [Google Scholar] [CrossRef]
- Hussain, A.; Mahawar, K.; Xia, Z.; Yang, W.; El-Hasani, S. Obesity and mortality of COVID-19. Meta analysis. Obes. Res. Clin. Pract. 2020, 14, 295–300. [Google Scholar] [CrossRef] [PubMed]
- Cade, B.E.; Dashti, H.S.; Hassan, S.M.; Redline, S.; Karlson, E.W. Sleep apnea and COVID-19 mortality and hospitalization. Am. J. Respir. Crit. Care Med. 2020, 15, 1462. [Google Scholar] [CrossRef] [PubMed]
- Kar, A.; Saxena, K.; Goyal, A.; Pakhare, A.; Khurana, A.; Saigal, S.; Bhagtana, P.K.; Chinta, S.S.K.R.; Niwariya, Y. Assessment of obstructive sleep apnea in association with severity of COVID-19: A prospective observational study. Sleep Vigil. 2021, 6, 111–118. [Google Scholar] [CrossRef]
- Maas, M.B.; Kim, M.; Malkani, R.G.; Abbott, S.M.; Zee, P.C. Obstructive sleep apnea and risk of COVID-19 infection, hospitalization and respiratory failure. Sleep Breath. 2020, 29, 1155–1157. [Google Scholar] [CrossRef]
- Iannella, G.; Vicini, C.; Lechien, J.R.; Ravaglia, C.; Poletti, V.; di Cesare, S.; Amicarelli, E.; Gardelli, L.; Grosso, C.; Patacca, A.; et al. Association between severity of COVID-19 respiratory disease and risk of obstructive sleep apnea. Ear Nose Throat J. 2021. [Google Scholar] [CrossRef]
- Feuth, T.; Saaresranta, T.; Karlsson, A.; Valtonen, M.; Peltola, V.; Rintala, E.; Oksi, J. Is sleep apnea a risk factor for Covid-19? findings from a retrospective cohort study. Sleep Med. Dis. Int. J. 2020, 4, 61–65. [Google Scholar] [CrossRef]
- Memtsoudis, S.G.; Ivascu, N.S.; Pryor, K.O.; Goldstein, P.A. Obesity as a risk factor for poor outcome in COVID-19-induced lung injury: The potential role of undiagnosed obstructive sleep apnoea. Br. J. Anaesth. 2020, 125, 262–263. [Google Scholar] [CrossRef]
- Strausz, S.; Kiiskinen, T.; Broberg, M.; Ruotsalainen, S.; Koskela, J.; Bachour, A.; Palotie, A.; Palotie, T.; Ripatti, S.; Ollila, H.M. Sleep apnoea is a risk factor for severe COVID-19. BMJ Open Respir. Res. 2021, 8, e000845. [Google Scholar] [CrossRef]
- Hariyanto, T.I.; Kurniawan, A. Obstructive sleep apnea (OSA) and outcomes from coronavirus disease 2019 (COVID-19) pneumonia: A systematic review and meta-analysis. Sleep Med. 2021, 82, 47–53. [Google Scholar] [CrossRef] [PubMed]
- Ekiz, T.; İnönü Köseoğlu, H.; Pazarlı, A.C. Obstructive sleep apnea, renin-angiotensin system, and COVID-19: Possible interactions. J. Clin. Sleep Med. 2020, 16, 1403–1404. [Google Scholar] [CrossRef] [PubMed]
- Jin, Z.N.; Wei, Y.X. Meta-analysis of effects of obstructive sleep apnea on the renin-angiotensin-aldosterone system. J. Geriatr. Cardiol. 2016, 13, 333–343. [Google Scholar] [PubMed]
- McSharry, D.; Malhotra, A. Potential influences of obstructive sleep apnea and obesity on COVID-19 severity. J. Clin. Sleep Med. 2020, 16, 1645. [Google Scholar] [CrossRef] [PubMed]
- Salles, C.; Mascarenhas Barbosa, H. COVID-19 and obstructive sleep apnea. J. Clin. Sleep Med. 2020, 16, 1647. [Google Scholar] [CrossRef]
- McSharry, D.; Lam, M.T.; Malhotra, A. OSA as a probable risk factor for severe COVID-19. J. Clin. Sleep Med. 2020, 16, 1649. [Google Scholar] [CrossRef]
- Leisman, D.E.; Ronner, L.; Pinotti, R.; Taylor, M.D.; Sinha, P.; Calfee, C.S.; Hirayama, A.V.; Mastroiani, F.; Turtle, C.J.; Harhay, M.O.; et al. Cytokine elevation in severe and critical COVID-19: A rapid systematic review, meta-analysis, and comparison with other inflammatory syndromes. Lancet Respir. Med. 2020, 8, 1233–1244. [Google Scholar] [CrossRef]
- Considerations for the Practice of Sleep Medicine during COVID-19. Available online: https://aasm.org/covid-19-resources/considerations-practice-sleep-medicine/ (accessed on 22 June 2021).
- Schiza, S.; Simonds, A.; Randerath, W.; Fanfulla, F.; Testelmans, D.; Grote, L.; Montserrat, J.M.; Pepin, J.L.; Verbraecken, J.; Ersu, R.; et al. Sleep laboratories reopening and COVID-19: A European perspective. Eur. Respir. J. 2021, 57, 2002722. [Google Scholar] [CrossRef]
- Infectious Diseases Society of America Guidelines on Infection Prevention in Patients with Suspected or Known COVID-19. Available online: https://www.idsociety.org/practice-guideline/covid-19-guideline-infection-prevention/ (accessed on 28 June 2021).
- Kole, A.S. Home sleep testing in the era of COVID-19: A community perspective. J. Clin. Sleep Med. 2020, 16, 1633. [Google Scholar] [CrossRef]
- Association for Respiratory Technology and Physiology (ARTP) COVID Group. Guidelines for Recommencing Physiological Services during the Coronavirus Disease 2019 (COVID-19) Endemic Phase. Available online: www.artp.org.uk/COVID19 (accessed on 24 June 2021).
- Montserrat, J.M.; Javier Puertas, F.; Egea, C.; Embid, C.; Matute-Villacís, M.; de Manuel Martínez, L.; Orteu, Á.; González-Cappa, J.; Tato Cerdeiras, M.; Mediano, O. Spanish Society of Pulmonology and Thoracic Surgery positioning on the use of telemedine in sleep-disordered breathing and mechanical ventilation. Posicionamiento de la Sociedad Española de Neumología y Cirugía Torácica en el uso de la telemedicina en los trastornos respiratorios del sueño y ventilación mecánica. Arch. Bronconeumol. 2021, 57, 281–290. [Google Scholar]
- Insalaco, G.; Dal Farra, F.; Braghiroli, A.; Sacco Salvaggio, A.; on behalf of the Italian Thoracic Society (ITS-AIPO). Sleep breathing disorders in the COVID-19 era: Italian Thoracic Society organizational models for a correct approach to diagnosis and treatment. Respiration 2020, 99, 690–694. [Google Scholar] [CrossRef] [PubMed]
- Gupta, R.; Kumar, V.M.; Tripathi, M.; Datta, K.; Narayana, M.; Ranjan Sarmah, K.; Bhatia, M.; Devnani, P.; Das, S.; Shrivastava, D.; et al. Guidelines of the Indian Society for Sleep Research (ISSR) for Practice of Sleep Medicine during COVID-19. Sleep Vigil. 2020, 4, 61–72. [Google Scholar] [CrossRef]
- Garrouste-Orgeas, M.; Flahault, C.; Vinatier, I.; Rigaud, J.P.; Thieulot-Rolin, N.; Mercier, E.; Rouget, A.; Grand, H.; Lesieur, O.; Tamion, F.; et al. Effect of an ICU diary onposttraumatic stress disorder symptoms among patients receiving mechanical ventilation: A randomized clinical trial. JAMA 2019, 322, 229–239. [Google Scholar] [CrossRef] [Green Version]
- Kotfis, K.; Williams Roberson, S.; Wilson, J.E.; Dabrowski, W.; Pun, B.T.; Ely, E.W. COVID-19: ICU delirium management during SARS-CoV-2 pandemic. Crit. Care 2020, 24, 176. [Google Scholar] [CrossRef]
- Zhang, Q.; Gao, F.; Zhang, S.; Sun, W.; Li, Z. Prophylactic use of exogenous melatonin and melatonin receptor agonists to improve sleep and delirium in the intensive care units: A systematic review and meta-analysis of randomized controlled trials. Sleep Breath. 2019, 23, 1059–1070. [Google Scholar] [CrossRef]
- Zhang, R.; Wang, X.; Ni, L.; Di, X.; Ma, B.; Niu, S.; Liu, C.; Reiter, R.J. COVID-19: Melatonin as a potential adjuvant treatment. Life Sci. 2020, 250, 117583. [Google Scholar] [CrossRef]
- Wu, G.C.; Peng, C.K.; Liao, W.I.; Pao, H.P.; Huang, K.L.; Chu, S.J. Melatonin receptor agonist protects against acute lung injury induced by ventilator through up-regulation of IL-10 production. Respir. Res. 2020, 21, 65. [Google Scholar] [CrossRef] [Green Version]
- Lenze, E.J.; Mattar, C.; Zorumski, C.F.; Stevens, A.; Schweiger, J.; Nicol, G.E.; Miller, J.P.; Yang, L.; Yingling, M.; Avidan, M.S.; et al. Fluvoxamine vs placebo and clinical deterioration in outpatients with symptomatic COVID-19: A randomized clinical trial. JAMA 2020, 324, 2292–2300. [Google Scholar] [CrossRef] [PubMed]
- Anderson, G.M. Fluvoxamine, melatonin and COVID-19. Psychopharmacology 2021, 238, 611. [Google Scholar] [CrossRef]
- Plaze, M.; Attali, D.; Petit, A.C.; Blatzer, M.; Simon-Loriere, E.; Vinckier, F.; Cachia, A.; Chrétien, F.; Gaillard, R. Repurposing chlorpromazine to treat COVID-19: The reCoVery study. Encephale 2020, 46, 169–172. [Google Scholar] [CrossRef] [PubMed]
- Jansen van Vuren, E.; Steyn, S.F.; Brink, C.B.; Möller, M.; Viljoen, F.P.; Harvey, B.H. The neuropsychiatric manifestations of COVID-19: Interactions with psychiatric illness and pharmacological treatment. Biomed. Pharmacother. 2021, 135, 111200. [Google Scholar] [CrossRef] [PubMed]
- Altena, E.; Baglioni, C.; Espie, C.A.; Ellis, J.; Gavriloff, D.; Holzinger, B.; Schlarb, A.; Frase, L.; Jernelöv, S.; Riemann, D. Dealing with sleep problems during home confinement due to the COVID-19 outbreak: Practical recommendations from a task force of the European CBT-I academy. J. Sleep Res. 2020, 29, 3052. [Google Scholar] [CrossRef]
- Shamim-Uzzaman, Q.A.; Bae, C.J.; Ehsan, Z.; Setty, A.R.; Devine, M.; Dhankikar, S.; Donskoy, I.; Fields, B.; Hearn, H.; Hwang, D.; et al. The use of telemedicine for the diagnosis and treatment of sleep disorders: An American Academy of Sleep Medicine update. J. Clin. Sleep Med. 2021, 17, 1103. [Google Scholar] [CrossRef]
- Xiao, C.X.; Lin, Y.J.; Lin, R.Q.; Liu, A.N.; Zhong, G.Q.; Lan, C.F. Effects of progressive muscle relaxation training on negative emotions and sleep quality in COVID-19 patients: A clinical observational study. Medicine 2020, 99, 47. [Google Scholar] [CrossRef]
- Holmes, E.A.; O’Connor, R.C.; Perry, V.H.; Tracey, I.; Wessely, S.; Arseneault, L.; Ballard, C.; Christensen, H.; Cohen Silver, R.; Everall, I.; et al. Multidisciplinary research priorities for the COVID-19 pandemic: A call for action for mental health science. Lancet Psychiatry 2020, 7, 43. [Google Scholar] [CrossRef]
- Crew, E.C.; Baron, K.G.; Grandner, M.A.; Ievers-Landis, C.E.; McCrae, C.S.; Nadorff, M.R.; Nowakowski, S.; Ochsner Margolies, S.; Hansen, K. The Society of Behavioral Sleep Medicine (SBSM) COVID-19 Task Force: Objectives and summary recommendations for managing sleep during a pandemic. Behav. Sleep Med. 2020, 18, 570–572. [Google Scholar] [CrossRef] [PubMed]
- Partinen, M.; Bjorvatn, B.; Holzinger, B.; Chung, F.; Penzel, T.; Espie, C.A.; Morin, C.M.; ICOSS-Collaboration Group. Sleep and circadian problems during the coronavirus disease 2019 (COVID-19) pandemic: The International COVID-19 Sleep Study (ICOSS). J. Sleep Res. 2020, 30, 13206. [Google Scholar] [CrossRef] [PubMed]
- Cenat, J.M.; Blais-Rochette, C.; Kokou-Kpolou, C.K.; Noorishad, P.G.; Mukunzi, J.N.; McIntee, S.E.; Dalexis, R.D.; Goulet, M.A.; Labelle, P.R. Prevalence of symptoms of depression, anxiety, insomnia, posttraumatic stress disorder, and psychological distress among populations affected by the COVID-19 pandemic: A systematic review and meta-analysis. Psychiatry Res. 2021, 295, 113599. [Google Scholar] [CrossRef] [PubMed]
Author/Year | Sample | Type of Study | Aim | Results |
---|---|---|---|---|
Alimoradi, 2021 [14] | 168 cross-sectional, four case-control, and five longitudinal design papers comprising 345,270 participants (general population, HCPs, and COVID-19 patients) | Systematic review and meta-analysis | Assess sleep problems during the COVID-19 pandemic and its relationship with psychological distress |
|
Jahrami, 2021 [15] | 44 papers, involving a total of 54,231 participants from 13 countries (general population, HCPs, and patients with COVID-19) | Systematic review and meta-analysis | Examine the impact of the pandemic on sleep problems prevalence |
|
Jiang, 2021 [24] | 202 patients who were hospitalized in different pandemic stages in a single center in Wuhan (109 on February and 93 on March 2020) | Cross-sectional study | Evaluate the mental distress and sleep quality of patients by questionnaires SAS, SDS, and PSQI |
|
Liu, 2021 [27] | 324 COVID 19 patients in Shenzhen during the recovery period | Retrospective cohort | Analysis of the epidemiological information, discharge summaries, and laboratory results of patients |
|
Xu, 2021 [28] | 121 confirmed COVID-19 patients, from Anhui Provincial Hospital and Anqing Hospital | On-site psychological investigation | Insomnia and depression symptoms were evaluated through the ISI and the CES-D in the recovered COVID-19 patients two weeks after discharge |
|
Liguori, 2020 [36] | 103 patients hospitalized at the University Hospital of Rome “Tor Vergata” | Observational study | Evaluation of subjective neurological symptoms |
|
Fontera, 2021 [37] | 4491 patients hospitalized with COVID-19 with 13.5% developing a new neurologic disorder | Prospective, multicenter, observational study | Evaluation of new neurologic disorders prevalence, in-hospital mortality, and discharge disposition between patients with COVID-19 with and without neurologic disorders |
|
Vitale, 2020 [44] | 4 cases, Lombardy Italy | Case series | Determining sleep quality with sleep diaries, PSQI, and wrist actigraphy |
|
Zhang, 2020 [45] | 135 patients (60 in good-sleep group and 75 in poor-sleep group) Wuhan Union Hospital, China | Retrospective, single-center cohort | Investigate the effects of sleep quality on recovery from lymphopenia and clinical outcomes in hospitalized patients with laboratory-confirmed COVID-19 with RCSQ and PSQI |
|
Huang, 2020 [49] | 203 adults infected with COVID-19 and 228 uninfected adults in three Chinese provinces, with 80.7% of the infected and 82.5% of uninfected | Multicenter, retrospective cohort study | Discover how physical activity and lifestyle affect the epidemic as well as the disease severity and prognosis of COVID-19 patients by answering a doctor-administered telephone questionnaire on lifestyle |
|
Dai, 2020 [54] | 307 patients admitted to Fangcang shelter hospitals | Cross-sectional study | Evaluate the prevalence and major influencing factors of anxiety and depressive symptoms among COVID-19 patients via an anonymous online questionnaire consisting of a set of items on demographic and clinical characteristics, the Self-Rating Anxiety Scale, Self-Rating Depression Scale, and PSQI |
|
Huang, 2021 [55] | 1733 of 2469 discharged patients with COVID-19 from Jin Yin-tan Hospital (Wuhan, China) | Ambidirectional cohort study | Describe the long-term health consequences of patients who have been discharged and investigate the associated risk factors with a series of questionnaires for evaluation of symptoms and health-related quality of life, physical examination, 6-min walking test, and blood tests |
|
Deng, 2021 [56] | 31 studies (n = 5153) | Systematic review and random-effects meta-analysis | Assess the prevalence of depression, anxiety, and sleep disturbances in COVID-19 patients |
|
Liu, 2020 [57] | 21 hospitalized patients with schizophrenia with suspected COVID-19 in the isolation ward of a mental health hospital in Wuhan and 30 hospitalized patients with schizophrenia in the general ward of another mental health hospital in Yichang, China (clean group) | Retrospective study | Explore the clinical characteristics of hospitalized patients with schizophrenia with suspected COVID-19. PSQI scores used for sleep quality |
|
Author/Year | Sample | Type of Study | Aim | Results |
---|---|---|---|---|
Cade, 2020 [61] | 4668 patients 443 participants (9.5%) with sleep apnea | Observational study | Analyze electronic health record data from a large New England health care system to assess whether sleep apnea is an unrecognized risk factor for COVID-19-related death, hospitalization, ventilator use, and ICU admission among COVID-19 patients |
|
Kar, 2021 [62] | 213 patients | Prospective observational study | Estimate the prevalence of OSA in COVID-19 patients using various screening questionnaires (STOP-BANG, Berlin Questionnaire, NoSAS, and Epworth Scale) and assess OSA effect on outcome of disease |
|
Maas, 2021 [63] | 9405 participants with COVID-19 infections, 3185 (34%) were hospitalized, and 1779 (19%) with respiratory failure | Observational study | Evaluate the risk for COVID-19 diagnosis, hospitalization, and respiratory failure associated with OSA, and assess potential association between OSA, COVID-19 hospitalization, and progression to respiratory failure from the data of an electronic medical record system of 10 hospitals in the Chicago metropolitan area. |
|
Iannella, 2021 [64] | 96 patients Group 1 (72 patients): hospitalized patients undergoing conventional oxygen therapy Group 2 (24 patients): patients requiring enhanced respiratory support | Observational retrospective study | Evaluate the association between the severity of COVID-19 respiratory illness and the risk of developing OSA using STOP-BANG |
|
Feuth, 2020 [65] | 28 patients | Retrospective cohort study | Explore baseline characteristics to identify risk for severe disease and critical care admission in Turku University Hospital |
|
Memtsoudis, 2020 [66] | 124 severely and critically ill patients with respiratory failure (ICU n = 60, non-ICU n = 64) | Observational study | Explore if OSA is a potential contributor to high morbidity amongst severely and critically ill COVID-19 patients with respiratory failure |
|
Strausz, 2021 [67] | 260,405 Finnish individuals from FinnGen Data Freeze 6 with 445 patients with COVID-19 | Observational study | Study if OSA is an independent risk factor for COVID-19 infection or for severe COVID-19 |
|
Hariyanto, 2021 [68] | 21 studies with 54,276 COVID-19 patients | Systematic review and meta-analysis | Analyze the relationship between OSA and poor outcomes of COVID-19 |
|
Prevention | Early and accurate recognition of sleep dysfunction and psychological distress |
Personalized treatment | |
Improve sleep hygiene | Adopt measures to reduce noise and lightening |
Chronotherapy | |
Ensure privacy by separating patients from each other during hospitalization | |
Provide psychological and emotional support | |
Provide proper sedation and analgesia when needed | |
Medication strategies | Melatonin and melatonin receptor agonists |
Melatonin should be considered as a first-line agent to treat sleep–wake rhythm disorders | |
Insomnia |
|
| |
| |
Obstructive sleep apnea (OSA) | Each sleep laboratory should adapt according to the local prevalence of COVID-19 |
Home sleep testing is preferred in uncomplicated patients | |
During the COVID-19 pandemic, home PAP could be applied using telemonitoring in uncomplicated patients | |
Telemedicine may be used for the evaluation and follow up |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Pataka, A.; Kotoulas, S.; Sakka, E.; Katsaounou, P.; Pappa, S. Sleep Dysfunction in COVID-19 Patients: Prevalence, Risk Factors, Mechanisms, and Management. J. Pers. Med. 2021, 11, 1203. https://doi.org/10.3390/jpm11111203
Pataka A, Kotoulas S, Sakka E, Katsaounou P, Pappa S. Sleep Dysfunction in COVID-19 Patients: Prevalence, Risk Factors, Mechanisms, and Management. Journal of Personalized Medicine. 2021; 11(11):1203. https://doi.org/10.3390/jpm11111203
Chicago/Turabian StylePataka, Athanasia, Seraphim Kotoulas, Elpitha Sakka, Paraskevi Katsaounou, and Sofia Pappa. 2021. "Sleep Dysfunction in COVID-19 Patients: Prevalence, Risk Factors, Mechanisms, and Management" Journal of Personalized Medicine 11, no. 11: 1203. https://doi.org/10.3390/jpm11111203
APA StylePataka, A., Kotoulas, S., Sakka, E., Katsaounou, P., & Pappa, S. (2021). Sleep Dysfunction in COVID-19 Patients: Prevalence, Risk Factors, Mechanisms, and Management. Journal of Personalized Medicine, 11(11), 1203. https://doi.org/10.3390/jpm11111203